{"nct_id":"NCT02734160","title":"A Study of Galunisertib (LY2157299) and Durvalumab (MEDI4736) in Participants With Metastatic Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2019-08-01","start_date":"2016-06-15","start_date_type":"ACTUAL","primary_completion_date":"2018-08-02","primary_completion_date_type":"ACTUAL","completion_date":"2019-04-17","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}